Universal Registration Document 2025

Table of delegations of authority and authorizations in force granted to the Board of Directors in respect of financial matters
Type of delegation or authorization	Date of the Meeting	Term of delegation/expiry	Amount authorized	Usage in 2025
Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums^*	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Date of the Meeting May 29, 2024 (21^st resolution)	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Term of delegation/expiry 26 months/ July 29, 2026^**	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Amount authorized Maximum nominal amount: €30,000,000⁽¹⁾	Delegation to increase the share capital by incorporating reserves, earnings, premiums or other sums ^* Usage in 2025 None
Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company^*	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Date of the Meeting May 29, 2024 (22^nd resolution)	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Term of delegation/expiry 26 months/ July 29, 2026^**	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Amount authorized Maximum nominal amount: €9,000,000⁽¹⁾ ⁽³⁾ Maximum nominal amount of debt securities: €1,200,000,000⁽²⁾	Delegation to issue shares or securities, without preferential subscription rights, in the event of a public offering initiated by the Company ^* Usage in 2025 None
Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer^*	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Date of the Meeting May 29, 2024 (23^rd resolution)	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Term of delegation/expiry 26 months/ July 29, 2026^**	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Amount authorized Maximum nominal amount: €9,000,000⁽¹⁾ ⁽³⁾ Maximum nominal amount of debt securities: €1,200,000,000⁽²⁾	Delegation to issue shares or other securities, without preferential subscription rights, in consideration for contributions in kind granted to the Company, except in the case of a public exchange offer ^* Usage in 2025 None
Issues reserved for Company or Groupe employees and managers
Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Date of the Meeting May 29, 2024 (24^th resolution)	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Term of delegation/expiry 38 months/ July 29, 2027	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Amount authorized No more than 3% of the share capital (including 0.3% of the share capital for executive corporate officers)	Authorization to grant existing or to be issued free shares to employees and/or corporate officers of the Company or Groupe companies Usage in 2025 Grant of 782,767 existing shares
Authorization to grant stock options to employees and/or corporate officers of the Company and the Groupe companies	Authorization to grant stock options to employees and/or corporate officers of the Company and the Groupe companies Date of the Meeting May 27, 2025 (19^th resolution)	Authorization to grant stock options to employees and/or corporate officers of the Company and the Groupe companies Term of delegation/expiry 38 months/ July 27, 2028	Authorization to grant stock options to employees and/or corporate officers of the Company and the Groupe companies Amount authorized No more than 3% of the share capital (including 0.3% of the share capital for executive corporate officers)⁽⁴⁾	Authorization to grant stock options to employees and/or corporate officers of the Company and the Groupe companies Usage in 2025 None
Delegation to increase capital for the benefit of subscribers to a Company savings plan	Delegation to increase capital for the benefit of subscribers to a Company savings plan Date of the Meeting May 27, 2025 (20^th resolution)	Delegation to increase capital for the benefit of subscribers to a Company savings plan Term of delegation/expiry 26 months/ July 27, 2027^**	Delegation to increase capital for the benefit of subscribers to a Company savings plan Amount authorized Maximum nominal amount: €2,800,000⁽¹⁾ ⁽⁵⁾	Delegation to increase capital for the benefit of subscribers to a Company savings plan Usage in 2025 None
Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Date of the Meeting May 27, 2025 (21^st resolution)	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Term of delegation/expiry 18 months/ November 27, 2026^**	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Amount authorized Maximum nominal amount: €2,800,000⁽¹⁾ ⁽⁵⁾	Delegation to increase the share capital for the benefit of certain categories of beneficiaries located outside France in order to establish a shareholder or savings plan for them Usage in 2025 None

This amount counts toward the €30,000,000 overall ceiling for all capital increases set forth by the General Shareholders’ Meeting of May 29, 2024 in its 16^th resolution.
This amount counts toward the €1,200,000,000 overall ceiling for all debt security issues set by the General Shareholders’ Meeting of May 29, 2024 in its 16^th resolution.
This amount counts towards the €9,000,000 overall ceiling for capital increases without preferential subscription rights set forth by the General Shareholders’ Meeting of May 29, 2024 in its 17^th resolution.
These ceilings count towards the 3% and the 0.3% ceilings set forth by the General Shareholders’ Meeting of May 29, 2024 in its 24^th resolution.
This ceiling applies to all possible capital increases under the 20^thand 21^st resolutions of the General Shareholders’ Meeting of May 27, 2025.

* Unless there is prior authorization by the General Shareholders’ Meeting, the Board of Directors cannot use this authorization or delegation from the time a third party has filed a public offer for Company shares up to the end of the offer period.
** This delegation or authorization is set to expire, for the unused portion and the remaining time period, upon adoption of a resolution pertaining to a new authorization or delegation with a similar purpose by the General Shareholders’ Meeting of May 27, 2026.
*** This delegation has become obsolete due to the changes introduced by the (French) Attractiveness Law of June 13, 2024 and will expire at the end of the General Shareholders’ Meeting of May 27, 2026.

It is specified that the delegations which expired during the 2025 financial year and which were not used during the said financial year are not mentioned in the above table, namely:

the 26^th resolution of the General Shareholders’ Meeting of May 25, 2022 was replaced by the 19^th resolution of the General Shareholders’ Meeting of May 27, 2025;
the 19^th resolution of the General Shareholders’ Meeting of May 31, 2023 was replaced by the 18^th resolution of the General Shareholders’ Meeting of May 27, 2025;
the 25^th and 26^th resolutions of the General Shareholders’ Meeting of May 29, 2024 were replaced by the 20^th and 21^st resolutions of the General Shareholders’ Meeting of May 27, 2025.

The share buybacks implemented in 2025 under the authorization approved in the 15^th resolution of the General Shareholders’ Meeting of May 29, 2024, which expired at the General Shareholders’ Meeting of May 27, 2025, are discussed in Section 8.3.3.

Universal Registration Document 2025

Board of directors